US STOCK
RDY Stock Analysis
US stocks · market data · technical indicators
Dr. Reddy's Laboratories Limited American Depositary Shares
RDYUS stocksQuote delayed 15 min
10/27 下午06:32 updated
$13.75
+0.54+4.09%
Open
$13.60
High
$13.86
Low
$13.60
Volume
412.20萬
RDY price history
+9.91%Open
12.51
Latest
13.75
High
13.75
Low
12.20
Average
12.77
Advertisement
Financial snapshot
RDY - Dr. Reddy's Laboratories Limited
EPS
0.38USD
Forward EPS
0.66USD
P/E
36.18x
Forward P/E
20.75x
P/B
16.75x
ROE
7.34%
ROA
3.37%
Operating margin
14.73%
Profit margin
8.49%
Revenue growth
-1.50%
Earnings growth
-35.70%
Dividend yield
0.61%
Financial statements
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| Revenue | $86.71B | $80.70B | $75.16B | $87.27B | $88.05B |
| Gross profit | $45.20B | $37.54B | $43.03B | $46.81B | $48.14B |
| Operating income | $12.81B | $3.03B | $829.00M | $14.33B | $18.18B |
| Net income | $9.25B | $4.43B | $2.21B | $12.10B | $14.37B |
| Basic EPS | 11.11 | 5.32 | 2.65 | 14.53 | 17.26 |
| Diluted EPS | 11.10 | 5.32 | 2.65 | 14.52 | 17.25 |
Estimates vs actuals
Next earnings
2027-01-21
EPS estimate
—
Revenue estimate
$90.49B
Last surprise
+11.56%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2027-01-21 | — | Not reported | — |
| 2025-05-09 | 17.13 | 19.11 | +11.56% |
| 2025-01-23 | 16.15 | 16.94 | +4.86% |
| 2024-11-05 | 17.69 | 15.83 | -10.54% |
| 2024-07-27 | 17.12 | 16.70 | -2.50% |
| 2024-05-07 | 13.55 | 15.54 | +14.70% |
| 2024-01-30 | 13.26 | 16.64 | +25.43% |
| 2023-10-27 | 11.60 | 17.81 | +53.56% |
| 2023-07-26 | 10.51 | 16.85 | +60.42% |
| 2023-05-10 | 10.90 | 12.00 | +10.16% |
| 2023-01-25 | 9.55 | 14.84 | +55.33% |
| 2022-10-28 | 9.39 | 13.50 | +43.74% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $137.3M | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $106.5M | 0.15% |
| VANGUARD GROUP INC | 2025-12-31 | $70.6M | 0.00% |
| STATE STREET CORP | 2026-06-30 | $59.8M | 0.00% |
| CITADEL ADVISORS LLC | 2026-06-30 | $1.1M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$14.28
Target range
$12.47 – $15.66
Implied upside
3.83%
Strong buy
1
Buy
2
Hold
2
Sell
0
Strong sell
0
Dividends
Annual yield
0.47%
Frequency
Annual
Recent payouts
- 2026-07-24$0.0643
- 2025-07-25$0.0715
- 2024-07-30$0.4042
Advertisement